Alembic Pharmaceuticals gets USFDA final approval for fluorouracil injection
Fluorouracil Injection is indicated for the treatment of patients with adenocarcinoma of colon and rectum and breast
Fluorouracil Injection is indicated for the treatment of patients with adenocarcinoma of colon and rectum and breast
lAIH strives to introduce appropriate interventions for nurturing an AMR innovation ecosystem in the country through cohesive efforts across the innovation pyramid
Smart-performance, fully biodegradable biopolymer sourced from renewable raw materials
Julie is recognized as a highly engaging multi-cultural leader skilled in fluidly partnering with cross-functional teams to deliver results.
Rocuronium Bromide Injection is a neuromuscular blocking agent
AstraZeneca and Merck are committed to working with the FDA to bring LYNPARZA in combination with abi/pred to patients diagnosed with mCRPC.
Julian Collins, Jana Windt and Michiel Stork join biopharma company’s leadership team
This order is subject to initial advance payment as per the agreed terms of the contract and this order will be executed within 6 to 8 months.
The portfolio includes approximately 45 commercial products, four pipeline products and 40 approved non-marketed products, including a number of generic products focused on women’s health.
Jan Aushadhi Diwas celebrations to generate awareness about the usages of generic medicines and benefits of Jan Aushadhi Pariyojana
Subscribe To Our Newsletter & Stay Updated